Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C

Technology appraisal guidance
Reference number: TA106
Published: 23 August 2006
Last updated: 27 November 2013

TA106 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive

TA106 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive

TA106 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive
20 December 2013
(111.64 Kb 32 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 18 December 2013